Baird raised the firm’s price target on Labcorp (LH) to $289 from $282 and keeps an Outperform rating on the shares. The firm said they posted a strong quarterly update on Diagnostic strength and improved BLS P&L performance, despite largely temporary headwinds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $249 from $234 at Barclays
- Morning Movers: UPS ascends and Textron descends after quarterly reports
- Labcorp reports Q3 adjusted EPS $3.50, consensus $3.48
- Labcorp narrows FY24 adjusted EPS view to $14.30-$14.70 from $14.30-$14.90
- Notable companies reporting before tomorrow’s open